Additionally, we found that rubiadin significantly decreased the serum iron (SI), transferrin saturation (TF%) levels and duodenal iron content and relieved splenomegaly and increased the hepatic hepcidin in high-iron-fed mice. The gene discussed is TF; the disease is Splenomegaly.